Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.

PHASE3CompletedINTERVENTIONAL
Enrollment

752

Participants

Timeline

Start Date

February 1, 2001

Primary Completion Date

November 12, 2001

Study Completion Date

November 12, 2001

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Insulin detemir

DRUG

NPH insulin

Trial Locations (93)

1210

Novo Nordisk Investigational Site, Luxembourg

1702

Novo Nordisk Investigational Site, Sarpsborg

2000

Novo Nordisk Investigational Site, Frederiksberg

2050

Novo Nordisk Investigational Site, Jessheim

2226

Novo Nordisk Investigational Site, Kongsvinger

2292

Novo Nordisk Investigational Site, Broadmeadow

2400

Novo Nordisk Investigational Site, Copenhagen

2605

Novo Nordisk Investigational Site, Garran

2650

Novo Nordisk Investigational Site, Edegem

Novo Nordisk Investigational Site, Hvidovre

2880

Novo Nordisk Investigational Site, Bornem

3000

Novo Nordisk Investigational Site, Leuven

3128

Novo Nordisk Investigational Site, Box Hill

3134

Novo Nordisk Investigational Site, Ringwood

3168

Novo Nordisk Investigational Site, Clayton

4011

Novo Nordisk Investigational Site, Stavanger

4120

Novo Nordisk Investigational Site, Stones Corner

5000

Novo Nordisk Investigational Site, Odense

5011

Novo Nordisk Investigational Site, Woodville

5035

Novo Nordisk Investigational Site, Ashford

5400

Novo Nordisk Investigational Site, Stord

7000

Novo Nordisk Investigational Site, Fredericia

7006

Novo Nordisk Investigational Site, Trondheim

7100

Novo Nordisk Investigational Site, Vejle

8000

Novo Nordisk Investigational Site, Århus C

9000

Novo Nordisk Investigational Site, Ghent

11108

Novo Nordisk Investigational Site, Narbonne

17019

Novo Nordisk Investigational Site, La Rochelle

34295

Novo Nordisk Investigational Site, Montpellier

35056

Novo Nordisk Investigational Site, Rennes

49033

Novo Nordisk Investigational Site, Angers

58033

Novo Nordisk Investigational Site, Nevers

71200

Novo Nordisk Investigational Site, Le Creusot

75475

Novo Nordisk Investigational Site, Paris

75877

Novo Nordisk Investigational Site, Paris

75908

Novo Nordisk Investigational Site, Paris

80210

Novo Nordisk Investigational Site, Joensuu

84902

Novo Nordisk Investigational Site, Avignon

86000

Novo Nordisk Investigational Site, Poitiers

91106

Novo Nordisk Investigational Site, Corbeil-Essonnes

93143

Novo Nordisk Investigational Site, Bondy

94100

Novo Nordisk Investigational Site, Kemi

Unknown

Novo Nordisk Investigational Site, Middelfart

Novo Nordisk Investigational Site, Dublin

02740

Novo Nordisk Investigational Site, Espoo

00250

Novo Nordisk Investigational Site, Helsinki

01400

Novo Nordisk Investigational Site, Vantaa

DUBLIN 8

Novo Nordisk Investigational Site, Dublin

3816 CP

Novo Nordisk Investigational Site, Amersfoort

7334 DZ

Novo Nordisk Investigational Site, Apeldoorn

6442 BE

Novo Nordisk Investigational Site, Brunssum

5631 BM

Novo Nordisk Investigational Site, Eindhoven

2012 CE

Novo Nordisk Investigational Site, Haarlem

7555 DL

Novo Nordisk Investigational Site, Hengelo

2512 VA

Novo Nordisk Investigational Site, The Hague

3582 KE

Novo Nordisk Investigational Site, Utrecht

NO-5012

Novo Nordisk Investigational Site, Bergen

0284

Novo Nordisk Investigational Site, Oslo

0407

Novo Nordisk Investigational Site, Oslo

791 82

Novo Nordisk Investigational Site, Falun

251 87

Novo Nordisk Investigational Site, Helsingborg

651 85

Novo Nordisk Investigational Site, Karlstad

221 85

Novo Nordisk Investigational Site, Lund

701 85

Novo Nordisk Investigational Site, Örebro

541 85

Novo Nordisk Investigational Site, Skövde

141 86

Novo Nordisk Investigational Site, Stockholm

901 85

Novo Nordisk Investigational Site, Umeå

751 85

Novo Nordisk Investigational Site, Uppsala

331 85

Novo Nordisk Investigational Site, Värnamo

NP7 7EG

Novo Nordisk Investigational Site, Abergavenny

BB3 3LR

Novo Nordisk Investigational Site, Blackburn

BL1 4QS

Novo Nordisk Investigational Site, Bolton

BS10 5NB

Novo Nordisk Investigational Site, Bristol

PO6 3LY

Novo Nordisk Investigational Site, Cosham

DE7 1DY

Novo Nordisk Investigational Site, Derby

ME7 5NY

Novo Nordisk Investigational Site, Gillingham

G4 0SF

Novo Nordisk Investigational Site, Glasgow

G42 9TY

Novo Nordisk Investigational Site, Glasgow

GU2 7XX

Novo Nordisk Investigational Site, Guildford

NN16 8UZ

Novo Nordisk Investigational Site, Kettering

EH54 6PP

Novo Nordisk Investigational Site, Livingstone

CF72 8XR

Novo Nordisk Investigational Site, Llantrisant

SE1 7EH

Novo Nordisk Investigational Site, London

NE7 7DN

Novo Nordisk Investigational Site, Newcastle

NN1 5BD

Novo Nordisk Investigational Site, Northampton

NR1 3SR

Novo Nordisk Investigational Site, Norwich

NG5 1PB

Novo Nordisk Investigational Site, Nottingham

OX2 6HE

Novo Nordisk Investigational Site, Oxford

S5 7AU

Novo Nordisk Investigational Site, Sheffield

DA14 6LT

Novo Nordisk Investigational Site, Sidcup

SG1 4AB

Novo Nordisk Investigational Site, Stevenage

TA1 5DA

Novo Nordisk Investigational Site, Taunton

YO3 7HE

Novo Nordisk Investigational Site, York

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT03220425 - Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes. | Biotech Hunter | Biotech Hunter